What Fibromyalgia Is: Why the Pain Is Real and How Care Is Managed

Short Answer

If you're trying to understand what fibromyalgia is, think of it as a chronic pain-processing condition: your nervous system amplifies signals, causing widespread pain, fatigue, poor sleep, and "fibro fog." It is one of the most common rheumatic conditions — "considered the second most prevalent rheumatic condition" (IBRO Neuroscience Reports, 2026). Diagnosis is clinical because "No specific laboratory test, radiographic method, or biomarker has been identified for diagnosis" (Clinics (Sao Paulo), 2025). Fibro medicine may include duloxetine for fibromyalgia, pregabalin, or milnacipran — the three medicines FDA-approved for fibromyalgia — plus sleep repair, pacing, and graded activity.

In Welltory's own data, users who self-report fibromyalgia report heavy post-exertion crashes about 3x as often (63% vs 21%) and wake unrefreshed about 5.7x as often (28% vs 5%) as other users — yet their morning HRV and wellness scores read almost the same as everyone else's. One summary number misses the fibromyalgia crash.

How Welltory users who self-report fibromyalgia actually track

Among Welltory users who self-report fibromyalgia (n = 299, wearable-quality data) compared with users who do not (n = 3,846), the self-reported burden is dramatically higher, while the standard daily scores barely move:

• Heavy crashes after exertion: 63% vs 21% — about 3x as often.

• Waking up unrefreshed: 28% vs 5% — about 5.7x as often.

• Morning HRV score (median): 3.0 vs 3.1 — essentially identical.

• Morning wellness score (median): 94.1 vs 94.5 — no measurable difference; the spread between people is far larger than the gap.

The pattern is a subjective–objective split: people living with fibromyalgia feel the crash-and-unrefreshed cycle far more, but a single daily wellness or HRV number does not separate them from everyone else. The gap in reported crashes and poor sleep holds up even after accounting for how many other conditions a person reports, so it is not simply a by-product of having more diagnoses. This is association, not causation, and it comes from self-reported conditions rather than clinical diagnoses — but it is exactly why a one-number "how am I doing" score can look reassuring on a bad fibromyalgia day, and why the pattern over time matters more than any single reading.

The numbers behind this

n = 299 Welltory users who self-report fibromyalgia with wearable-quality data (of 1,086 self-reporting fibromyalgia total); comparison group n = 3,846 wearable-quality users without a self-reported fibromyalgia flag. Signals: self-reported "heavy crash after physical or mental effort," "wake up not restored," and wearable-derived morning HRV score and morning wellness score. Cohort defined by a self-report survey flag, not a clinical diagnosis; the flag's noise rate is not measured. The crash and poor-sleep gaps persist within strata of reported condition count (1 / 2 / 3+), so they are not explained by comorbidity load alone. The near-identical HRV/wellness score is a robust null: the group difference (~0.05 on the HRV score, ~0.4 on the wellness score) is a small fraction of the between-person spread (SD ~0.22 and ~6–10 respectively), and the wearable subgroup does not differ meaningfully from users who self-report fibromyalgia without wearable data. All figures are reported as anonymized, aggregated data; no individual user is identifiable.

Fibromyalgia at a glance

• Core mechanism — Central sensitization — the brain and spinal cord amplify pain signals; "Peripheral and central sensitization are thought to cause chronic pain in this disorder" (Clinics (Sao Paulo), 2025)

• Main symptoms — Widespread pain, fatigue, non-restorative sleep, and cognitive dysfunction ("fibro fog")

• Where the pain is — Widespread rather than limited to one joint: typically multiple body regions, often both sides of the body, and often the spine or torso

• Prevalence — "Fibromyalgia affects 2%-8% of the global population" (Frontiers in Pain Research, 2026)

• Who it affects — Female-biased; in nociplastic pain such as fibromyalgia, "women-biased hormonal fluctuations, limbic hyperconnectivity, and stress-immune interactions amplify central sensitization" (Frontiers in Neurology, 2025)

• Diagnosis — Clinical, using American College of Rheumatology criteria. The 2016 revision requires generalized pain in at least 4 of 5 body regions for at least 3 months, plus a Widespread Pain Index (WPI) ≥7 with a Symptom Severity Scale (SSS) score ≥5, or a WPI of 4–6 with an SSS ≥9 (2016 ACR revision)

• ICD-10 code — M79.7 (Fibromyalgia), per the official ICD-10-CM classification (CDC ICD-10-CM)

• Treatment — Layered: education, pacing, sleep work, graded activity, and clinician-chosen medication. Three medicines are FDA-approved for fibromyalgia — duloxetine, pregabalin, and milnacipran (Current and Emerging Pharmacotherapy for Fibromyalgia)

What fibromyalgia is — and why the pain is real

Fibromyalgia is not "just soreness," and it is not pain you are imagining. It is a chronic condition of the pain-processing system.

In many pain conditions, the body hurts because tissue is injured, a joint is inflamed, or a nerve is compressed. Fibromyalgia works differently. The main problem is that your brain and spinal cord become more reactive to signals coming from the body. Researchers call this central sensitization: "Peripheral and central sensitization are thought to cause chronic pain in this disorder" (Clinics (Sao Paulo), 2025).

That means ordinary body signals — pressure, temperature, movement, stress, poor sleep — can be turned up into real pain. Your nervous system is not faking it. It is amplifying.

This is why the question "is fibromyalgia a real disease?" has a clear answer: yes. Fibromyalgia is recognized in rheumatology and pain medicine, and it is "considered the second most prevalent rheumatic condition" (IBRO Neuroscience Reports, 2026).

It is also defined by a symptom pattern, not by one damaged structure. Fibromyalgia is "a common condition causing widespread pain, fatigue, sleep disturbance, and cognitive dysfunction" (Rheumatology and Therapy, 2026). You can feel pain in muscles, tendons, and soft tissues even when blood tests and scans do not show inflammation or injury.

That missing test is one reason people get dismissed. But "no single test" does not mean "not real." It means the diagnosis depends on the pattern your clinician sees. As one review states, "No specific laboratory test, radiographic method, or biomarker has been identified for diagnosis" (Clinics (Sao Paulo), 2025).

Where is the pain, and what are the symptoms?

Fibromyalgia pain is widespread. If you're asking "fibromyalgia where is the pain," the answer is usually not one joint or one injured spot. People often describe pain across several body regions — neck, shoulders, back, hips, arms, legs, or chest wall — with tenderness that can shift from day to day.

The pain may feel like a deep ache, burning, stiffness, bruising, or pressure sensitivity. Some people feel as if they have the flu all the time. Others say their body overreacts to touch, noise, temperature changes, or stress.

The core symptom cluster is:

• widespread body pain

• fatigue that is out of proportion to activity

• non-restorative sleep — sleeping but waking unrefreshed

• cognitive symptoms, often called "fibro fog"

• tenderness to pressure

• flares, when symptoms suddenly intensify

• overlap symptoms such as headaches, irritable bowel symptoms, dizziness, or mood changes

Sleep is not just a consequence of pain. It is part of the engine. In fibromyalgia, research describes "non-restorative sleep being a central symptom that severely exacerbates the condition" (Journal of Sleep Research, 2026). Poor sleep makes the nervous system more sensitive. More sensitivity makes pain louder. More pain makes sleep lighter. The loop keeps feeding itself.

Fibromyalgia flares

Fibromyalgia flares up in waves. A flare is a temporary worsening of pain, fatigue, sleep disruption, and fog. Common triggers include stress, illness, poor sleep, weather changes, and overexertion.

The frustrating part is that the trigger is not always obvious in the moment. You may feel fine during an activity, then crash hours or a day later. That delayed pattern matters, especially if you also have ME/CFS-like post-exertional malaise. It also shows up in our own data: Welltory users who self-report fibromyalgia log heavy post-exertion crashes about three times as often as other users (see the Short Answer), which is exactly the run-up that a single daily score tends to miss.

Tender points and the newer criteria

The older public image of fibromyalgia syndrome tender points still shapes how people talk about the condition. Some older studies record the "number of tender points" (Clinics (Sao Paulo), 2025).

Modern diagnosis has moved away from relying only on a tender-point exam. Clinicians now look at widespread pain plus symptom severity — especially fatigue, sleep quality, and cognitive symptoms. The 2016 revision to the American College of Rheumatology criteria scores a Widespread Pain Index (how many of 19 body areas hurt) alongside a Symptom Severity Scale that rates fatigue, unrefreshing sleep, and cognitive symptoms, rather than counting the old 18 tender points (2016 ACR revision).

What causes fibromyalgia?

There is no single cause. Fibromyalgia is best understood as a nociplastic pain condition: pain that comes from changed pain processing, not from ongoing tissue damage alone.

That change can be pushed by several forces at once — genetics, stress biology, infections, sleep disruption, trauma, immune signaling, hormones, and autonomic nervous system changes. In real life, many people can point to a "before and after": an illness, a major stressor, an injury, childbirth, surgery, or a long period of poor sleep. Others cannot identify one clear trigger.

Stress and trauma can raise risk

High-magnitude stress appears to matter. A large prospective military-cohort study found that combat deployment was linked with new fibromyalgia cases, and the relationship with PTSD was especially strong: "service members with PTSD predeployment were 2.96 times more likely to develop fibromyalgia post deployment" (Arthritis Care & Research, 2026).

That does not mean fibromyalgia is "psychological." It means stress systems and pain systems are physically connected. When your body is stuck in threat mode, the nervous system can become easier to trigger and harder to calm.

Infection may be a trigger

Fibromyalgia can also appear after infection. A controlled case-control study of people "diagnosed according to the 2016 American College of Rheumatology (ACR) criteria" (Journal of Clinical Medicine, 2026) found an association between post-COVID-19 infection and higher odds of meeting fibromyalgia criteria.

The body's immune response, sleep disruption, inactivity during illness, and autonomic changes may all contribute. The same person may have more than one trigger.

Sex differences are biological, not "bias"

Fibromyalgia is female-biased. The reason is not simply that women report pain more often. Pain processing, hormones, stress responses, and immune signaling can differ by sex. In nociplastic syndromes like fibromyalgia, "women-biased hormonal fluctuations, limbic hyperconnectivity, and stress-immune interactions amplify central sensitization" (Frontiers in Neurology, 2025).

How is fibromyalgia diagnosed?

Fibromyalgia is diagnosed clinically. That means your doctor uses your symptom pattern, exam, history, and basic testing to decide whether fibromyalgia fits — and whether something else could explain the symptoms better.

There is no single confirmatory blood test. No scan can "show" fibromyalgia in the way an X-ray can show a fracture. That can feel invalidating, but it is common in nervous-system disorders: the problem is in regulation and signal processing.

The usual framework is the American College of Rheumatology criteria, first issued in 2010 with a 2011 self-report modification and revised in 2016. In research and practice, patients are "diagnosed according to the 2016 American College of Rheumatology (ACR) criteria" (Journal of Clinical Medicine, 2026). These criteria combine widespread pain with symptom severity, rather than relying only on tender points.

The 2016 revision asks for generalized pain in at least 4 of 5 body regions, present at a similar level for at least 3 months, together with either a Widespread Pain Index (WPI) of 7 or more and a Symptom Severity Scale (SSS) score of 5 or more, or a WPI of 4–6 with an SSS of 9 or more (2016 ACR revision).

Ruling out look-alikes

When clinicians evaluate how to dx fibromyalgia, they usually also check for conditions that can mimic it, such as:

• thyroid disease

• anemia

• inflammatory arthritis

• autoimmune disease

• vitamin deficiencies

• sleep disorders

• medication side effects

• neurologic conditions when symptoms suggest them

Those tests do not diagnose fibromyalgia. They help make sure your pain and fatigue are not coming from something that needs different care.

What kind of doctor treats fibromyalgia?

A primary-care doctor can start the workup. Many people are then referred to a rheumatologist, especially when inflammatory arthritis or autoimmune disease needs to be ruled out. Pain specialists, neurologists, sleep clinicians, physical therapists, and mental health professionals may also be part of care.

If you are searching for "fibro doctors near me," "dr fibro," or fibromyalgia specialists doctors, the practical starting point is usually a primary-care visit or a rheumatology clinic. Bring a symptom timeline, medication list, sleep notes, and any flare or activity data you track.

ICD-10 code

For coding and insurance, the ICD-10-CM code for fibromyalgia is M79.7, per the official ICD-10-CM classification (CDC ICD-10-CM).

Fibromyalgia treatment and medicine

There is no cure that reliably switches fibromyalgia off for everyone. But symptoms can be managed, and many people improve when care is layered instead of one-dimensional.

The foundation is not "try harder." It is nervous-system care:

• reduce pain amplification

• improve sleep quality

• build activity tolerance without triggering crashes

• address mood, migraine, IBS, or other overlapping conditions when present

• use medication when the benefit is worth the risk, under clinician supervision

Medication

Common fibro medicine options discussed in fibromyalgia care include duloxetine, milnacipran, pregabalin, and off-label amitriptyline. Three of these — duloxetine, pregabalin, and milnacipran — are FDA-approved specifically for fibromyalgia (Current and Emerging Pharmacotherapy for Fibromyalgia). A cost-effectiveness modeling study evaluated "the cost-effectiveness of pregabalin, duloxetine, and milnacipran compared with amitriptyline in adults with moderate to severe FM" (JAMA Network Open, 2026).

Duloxetine for fibromyalgia is an SNRI, a medication class that affects serotonin and norepinephrine signaling. Those systems help regulate pain, mood, sleep, and stress response. Pregabalin works differently; it affects nerve signaling and may help pain and sleep in some people. Milnacipran is another SNRI used in fibromyalgia care.

Dosing, titration, contraindications, and medication choice must be individualized and set by a licensed clinician — do not start or adjust these medicines on your own. Specific label dosing is not listed here because it depends on your other conditions and is a prescribing decision.

Cardiovascular safety trade-off. These medicines are not risk-free. A large comparative study noted that "Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure" (Clinical Pharmacology & Therapeutics, 2026). That is one reason medication choice is individualized and monitored, especially if you have cardiovascular disease, high blood pressure, swelling, dizziness, or other autonomic symptoms. If you develop chest pain, fainting, an irregular or racing heartbeat, or severe shortness of breath, seek immediate medical attention. Wearable heart-rate and HRV trends may help you notice changes between visits, but they do not replace medical monitoring.

A note on pills for fibromyalgia pain: opioids are generally not recommended for fibromyalgia and are not part of the usual medication approach. In the EULAR management recommendations, the only "strong for" therapy-based recommendation is exercise, and opioids are advised against (EULAR revised recommendations).

Exercise and lifestyle

Exercising with fibromyalgia can help, but only when the plan respects your nervous system.

The goal is not to push through pain. The goal is to teach your body that movement is safe again, slowly enough that you do not trigger a flare. For many people, that means starting with less than they think they "should" be able to do: a few minutes of walking, gentle mobility, light strength work, water exercise, or stretching. Then you build gradually. Exercise is the treatment most strongly supported by fibromyalgia management guidelines (EULAR revised recommendations).

Exercise can improve function, pain coping, sleep, mood, and stamina over time. But if you crash after activity, your plan needs to change.

Fibromyalgia and fitness: the pacing caveat

Fibromyalgia and fitness advice can go wrong when it ignores post-exertional crashes. Some people with fibromyalgia also have ME/CFS-like symptoms, POTS, long COVID, or dysautonomia. In that subgroup, "exercise more" can backfire.

A better frame is pacing: staying inside an activity range your body can recover from. That may mean spacing out tasks, alternating physical and cognitive work, using rest before symptoms spike, and watching recovery signals over time.

This is where tracking earns its place. Because Welltory users who self-report fibromyalgia log heavy post-exertion crashes about three times as often as other users while their daily score barely moves, watching HRV and recovery trends over days — rather than a single reading — may help you see when your body is under strain before you feel the full crash.

Sleep and adjuncts

Sleep repair is care, not an afterthought. If your sleep is fragmented, too short, or non-restorative, your pain system becomes more reactive the next day. A sleep plan may include a sleep-disorder evaluation, clinician-guided insomnia care, pain timing strategies, light exposure, schedule consistency, and medication review.

A scoping review mapped "the therapeutic approaches, both pharmacological and non-pharmacological, that address sleep disturbances in FM patients" (Journal of Sleep Research, 2026). Autonomic-targeted approaches, including vagus-nerve-related interventions, are also being studied because fibromyalgia often involves autonomic imbalance (see §6).

Fibromyalgia and its overlaps: ME/CFS, POTS, dysautonomia, and sleep

Fibromyalgia often travels with other conditions. That is not random. Many overlapping syndromes involve central sensitization, autonomic dysregulation, immune stress, poor sleep, and altered recovery.

This is where tracking can be useful. Pain is subjective, but the body's stress and recovery systems leave signals: heart rate, sleep duration, sleep regularity, HRV, activity load, and how long it takes you to recover after exertion.

ME/CFS

Myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia are "debilitating disorders with overlapping symptoms such as chronic pain and fatigue" (Int. J. Molecular Sciences, 2026).

The key overlap is not just tiredness. It is post-exertional malaise, or PEM: a delayed worsening after physical, cognitive, or emotional effort. PEM can look like "I did one normal thing and lost the next day." If that pattern is present, pacing becomes more important than standard exercise progression.

POTS and dysautonomia

POTS — postural tachycardia syndrome — is an autonomic condition. One study described it as "a form of dysautonomia" and found that central sensitization is common in POTS. The authors concluded: "Central sensitization and autonomic impairment may coexist" (JAMA Network Open, 2026).

That matters because many people with fibromyalgia also report dizziness, racing heart, heat intolerance, shakiness, or feeling worse upright. Those symptoms should not be dismissed as "just anxiety." They may point to autonomic involvement that deserves evaluation.

The autonomic / HRV signature

Fibromyalgia itself has measurable autonomic changes. A systematic review described "autonomic imbalance (e.g., decreased heart rate variability)" (J. Functional Morphology & Kinesiology, 2025) in fibromyalgia.

HRV is not a diagnostic test for fibromyalgia. But it can be a useful recovery signal. Lower or unstable HRV may suggest your body is under more strain, especially when paired with poor sleep, higher resting heart rate, or a flare pattern. This is the physiological hook for tracking the condition with a wearable — and, as our own data shows, why the trend matters more than any single daily number.

Long COVID and multi-system fatigue

Long COVID shares symptoms with ME/CFS and fibromyalgia. One study described overlapping "brain fog, fatigue, muscle pain, and dysautonomia with orthostatic intolerance" (PLoS One, 2026).

If your fibromyalgia-like symptoms began after COVID-19 or another infection, tell your clinician. The label may affect which overlaps are checked: dysautonomia, sleep disorders, inflammatory disease, migraine, and post-exertional malaise.

Overlap with inflammatory rheumatic disease

Fibromyalgia can also layer on top of inflammatory disease. In psoriatic arthritis, studies show "between 18% and 64% of patients with PsA have fibromyalgia" (Rheumatology and Therapy, 2026).

That overlap can make inflammation look worse than it is. The same review warns that "disease activity indices often reflect fibromyalgia symptoms rather than true inflammation" (Rheumatology and Therapy, 2026). In practice, this matters because escalating immune-suppressing treatment may not help pain that is being driven by central sensitization.

Fibromyalgia is not all-or-nothing, either. Symptoms can build gradually. The review notes that "fibromyalgia symptoms exist along a continuum" (Rheumatology and Therapy, 2026).

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

All figures from Welltory's data are reported as anonymized, aggregated data; no individual user is identifiable. The cohort is defined by a self-report survey flag, not a clinical diagnosis, and reflects association rather than causation.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data